U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Activin receptor type 2 (synthetic human extracellular domain 109-amino acid fragment) fusion protein with peptide linker (GGG) fusion protein with immunoglobulin G1 (human ?1-chain Fc region), dimer
Preferred Name English
Rinvatercept
INN  
Official Name English
glycyl (1)-chimeric N-terminal (1-108)-peptide (2-109) combined from the sequences of the extracellular domains of the human activin type 2A and 2B receptors (ACTR-2A/B, ACVR2A/B, activin receptor type IIA/B, ACTR-IIA/B, EC:2.7.11.30), fused via a G3 pep
Common Name English
rinvatercept [INN]
Common Name English
Code System Code Type Description
INN
13442
Created by admin on Wed Apr 02 19:21:02 GMT 2025 , Edited by admin on Wed Apr 02 19:21:02 GMT 2025
PRIMARY
CAS
2996105-98-5
Created by admin on Wed Apr 02 19:21:02 GMT 2025 , Edited by admin on Wed Apr 02 19:21:02 GMT 2025
PRIMARY
FDA UNII
D674N274QK
Created by admin on Wed Apr 02 19:21:02 GMT 2025 , Edited by admin on Wed Apr 02 19:21:02 GMT 2025
PRIMARY
ACTIVE MOIETY
Rinvatercept
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966